Vividion Therapeutics’ proteomics screening platform and small molecule library will be leveraged by the San Diego-based company and Roche to target novel E3 ligases in addition to a variety of oncology and immunology therapy targets.
https://www.pharmalive.com/wp-content/uploads/2020/05/Vividion-and-Roche-Partner-on-Research-Pact-Worth-Several-Billion-Dollars-BioSpace-5-19-20.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2020-05-19 11:56:482020-05-22 22:58:53Vividion and Roche Partner on Research Pact